Momentum investing is essentially an exception to the idea of "buying low and selling high." Investors following this style of investing are usually not interested in betting on cheap stocks and waiting long for them to recover. Instead, they believe that "buying high and selling higher" is the way to make far more money in lesser time.Who doesn't like betting on fast-moving trending stocks? But determining the right entry point isn't easy. Often, these stocks lose momentum once their valuation moves ahead ...

Moretus Research delivers state-of-the-art, buy-side quality equity research for serious investors seeking clarity, conviction, and alpha. Focused on U.S. public markets, Moretus applies a structured, repeatable framework to identify companies with durable business models, mispriced cash flow potential, and intelligent capital allocation. Built on institutional standards, Moretus Research combines rigorous fundamental analysis with a high-signal, judgment-driven process—eschewing noise, narrative, and overl ...

Cardlytics (CDLX) came out with a quarterly loss of $0.21 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to loss of $0.09 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 22.22%. A quarter ago, it was expected that this company would post a loss of $0.24 per share when it actually produced break-even earnings, delivering a surprise of 100%.Over the last four quarters, the company has surpassed c ...

Cardlytics (CDLX) Q1 2025 Earnings Call May 07, 2025 05:00 PM ET Company Participants Nick Lynton - Chief Legal & Privacy OfficerAmit Gupta - CEOAlexis DeSieno - Chief Financial OfficerRobert Coolbrith - Vice President, Internet Equity Research Conference Call Participants Jacob Stephan - Senior Research AnalystLuke Horton - VP - Senior Equity Research AnalystCal Bartyzal - Equity Research Analyst Operator Ladies and gentlemen, thank you for standing by, and welcome to the Cardlytics Inc. Q1 twenty twenty f ...

Cardlytics (CDLX) Q1 2025 Earnings Call May 07, 2025 05:00 PM ET Speaker0 Ladies and gentlemen, thank you for standing by, and welcome to the Cardlytics Inc. Q1 twenty twenty five Earnings Conference Call. At this time, all participants' lines are in a listen only mode. Following the presentation, we will conduct a question and answer session. This call is being recorded on Wednesday, 05/07/2025. Now I would like to turn the call over to Nick Linton, Chief Legal and Privacy Officer. Please go ahead. Speaker ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________________ to _________________ Commission File Number: 001-38386 CARDLYTICS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware ...

Exhibit 99.1 Cardlytics Announces First Quarter 2025 Financial Results Atlanta, GA – May 7, 2025 – Cardlytics, Inc. (NASDAQ: CDLX), a digital advertising platform, today announced financial results for the first quarter ended March 31, 2025. "We've made marked progress across our key business pillars, which continue to underpin our journey to 'platformize' Cardlytics and position ourselves as the leading commerce media platform," said Amit Gupta, CEO of Cardlytics. "Our expanding ecosystem, depth and breadt ...

文章核心观点 Levi & Korsinsky, LLP 就 Cardlytics 公司证券欺诈提起集体诉讼，为受影响投资者追讨损失 [1] 案件详情 - 被告虚假陈述或隐瞒消费者参与度增加致激励成本上升 [2] - 公司无法随消费者参与度提升相应增加账单金额 [2] - 公司营收增长有显著放缓或下降风险 [2] - Ads Decision Engine 变更导致预算“交付不足”和客户账单估算问题 [2] - 被告对公司业务、运营和前景的积极表述具误导性或缺乏合理依据 [2] 后续安排 - 相关时间段内受损投资者需在 2025 年 3 月 25 日前申请成为首席原告 [3] - 不担任首席原告也可参与赔偿分配 [3] - 集体成员获赔偿无需支付额外费用 [3] 律所优势 - 过去 20 年为股东争取数亿美元赔偿，胜诉经验丰富 [4] - 擅长复杂证券诉讼，超 70 名员工服务客户 [4] - 连续 7 年位列美国证券诉讼律所前 50 [4] 联系方式 - 律所：Levi & Korsinsky, LLP [5] - 联系人：Joseph E. Levi, Esq.、Ed Korsinsky, Esq. [5] - 地址：33 Whitehall Street, 17th Floor, New York, NY 10004 [5] - 邮箱：[email protected] [5] - 电话：(212) 363 - 7500 [5] - 传真：(212) 363 - 7171 [5] - 网址：www.zlk.com [5]

文章核心观点 Gross Law Firm通知Cardlytics公司股东参与集体诉讼，指控公司在特定时期发布虚假或误导性声明，鼓励符合条件股东联系该律所，还介绍了截止日期、后续步骤及律所优势等信息 [1][2][3] 分组1：集体诉讼通知 - 律所鼓励在特定时期购买Cardlytics公司股票的股东联系，以争取成为首席原告，参与赔偿无需成为首席原告 [1] 分组2：集体诉讼相关信息 - 集体诉讼时间段为2024年3月14日至2024年8月7日 [2] - 指控被告在集体诉讼期间发布虚假或误导性声明，未披露消费者激励增加、账单无法随消费者参与度提升、营收增长可能放缓或下降、广告决策引擎更改导致预算和客户账单估计“交付不足”等情况，其对公司业务等的积极表述存在误导性或缺乏合理依据 [2] 分组3：截止日期与后续步骤 - 集体诉讼注册截止日期为2025年3月25日，股东应尽快注册 [3] - 注册后将被纳入投资组合监控软件以获取案件进展更新，申请成为首席原告的截止日期为2025年3月25日，参与案件无成本和义务 [3] 分组4：律所优势 - Gross Law Firm是全国知名集体诉讼律所，致力于保护因欺诈等受损投资者权益，确保公司遵守负责任商业行为和良好企业公民准则，为因公司虚假陈述等导致损失的投资者争取赔偿 [4] 分组5：律所联系方式 - 律所地址为纽约西38街15号12楼，邮箱为[email protected]，电话为(646) 453 - 8903 [5]

文章核心观点 - 律所Levi & Korsinsky代表受证券欺诈影响的Cardlytics投资者发起集体诉讼，指控被告虚假陈述和隐瞒关键信息 [1] 案件详情 - 被告虚假陈述和隐瞒内容包括：消费者参与度增加导致激励成本上升；公司无法随消费者参与度提升相应增加账单；营收增长有放缓或下降风险；广告决策引擎变更导致预算“交付不足”和客户账单估计偏差；被告对公司业务等积极表述具误导性或缺乏合理依据 [2] 后续安排 - 若在相关时间段内投资Cardlytics受损，需在2025年3月25日前申请成为首席原告，不担任首席原告也可参与赔偿分配 [3] 律所优势 - 过去20年Levi & Korsinsky为受害股东争取数亿美元赔偿，擅长复杂证券诉讼，有超70名员工，连续7年跻身美国证券诉讼律所前50 [4] 联系方式 - 律所Levi & Korsinsky联系信息：地址为纽约市白厅街33号17楼，邮编10004；邮箱[email protected]；电话(212) 363 - 7500；传真(212) 363 - 7171；网址www.zlk.com [5]